bf/NYSE:MED_icon.jpeg

NYSE:MED

Medifast, Inc.

  • Stock

USD

Last Close

19.15

25/09 14:39

Market Cap

204.85M

Beta: 1.27

Volume Today

34.47K

Avg: 241.26K

PE Ratio

4.73

PFCF: 3.26

Dividend Yield

9.50%

Payout:60.85%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
356.89M
-
285.29M
20.06%
272.77M
4.39%
274.53M
0.65%
301.56M
9.85%
501.00M
66.14%
713.67M
42.45%
934.84M
30.99%
1.53B
63.25%
1.60B
4.75%
1.07B
32.94%
cost of revenue
89.04M
-
76.08M
14.56%
71.46M
6.07%
68.87M
3.62%
73.75M
7.09%
121.10M
64.21%
176.81M
46.00%
237.03M
34.05%
398.49M
68.12%
458.16M
14.97%
296.20M
35.35%
gross profit
267.85M
-
209.21M
21.89%
201.31M
3.77%
205.66M
2.16%
227.81M
10.77%
379.90M
66.76%
536.86M
41.32%
697.82M
29.98%
1.13B
61.59%
1.14B
1.14%
775.85M
31.97%
selling and marketing expenses
5.30M
-
4.40M
16.98%
1.60M
63.64%
1.70M
6.25%
general and administrative expenses
440.52M
-
559.26M
26.95%
909.76M
62.67%
953.91M
4.85%
selling general and administrative expenses
234.26M
-
178.96M
23.60%
172.63M
3.54%
178.81M
3.58%
188.18M
5.24%
310.84M
65.18%
445.82M
43.43%
563.66M
26.43%
911.36M
61.69%
955.61M
4.86%
649.45M
32.04%
research and development expenses
2.70M
-
2.80M
3.70%
4.40M
57.14%
4.50M
2.27%
4.60M
2.22%
other expenses
91K
-
731K
703.30%
326K
55.40%
-20K
106.13%
136K
780%
179K
31.62%
29K
83.80%
-140K
582.76%
119K
185%
-46K
138.66%
-95K
106.52%
cost and expenses
323.30M
-
255.04M
21.11%
244.09M
4.29%
247.68M
1.47%
261.93M
5.76%
431.94M
64.91%
622.63M
44.15%
800.68M
28.60%
1.31B
63.59%
1.41B
7.93%
945.65M
33.11%
operating expenses
234.26M
-
178.96M
23.60%
172.63M
3.54%
178.81M
3.58%
188.18M
5.24%
310.84M
65.18%
445.82M
43.43%
563.66M
26.43%
911.36M
61.69%
955.61M
4.86%
649.45M
32.04%
interest expense
506K
-
716K
41.50%
661K
7.68%
283K
57.19%
558K
97.17%
1.31M
134.05%
231K
-
-701K
403.46%
ebitda
44.97M
-
30.25M
32.74%
28.68M
5.16%
26.86M
6.36%
39.63M
47.56%
69.06M
74.26%
91.04M
31.82%
134.16M
47.36%
223.05M
66.26%
195.79M
12.22%
139.51M
28.74%
operating income
33.59M
-
30.25M
9.96%
28.68M
5.16%
26.86M
6.36%
39.63M
47.56%
69.06M
74.26%
91.04M
31.82%
134.16M
47.36%
216.24M
61.18%
184.81M
14.54%
126.40M
31.60%
depreciation and amortization
11.38M
-
8.05M
29.26%
7.12M
11.64%
5.41M
24.03%
4.21M
22.13%
4.43M
5.37%
4.62M
4.26%
7.27M
57.22%
6.81M
6.30%
10.98M
61.19%
13.11M
19.37%
total other income expenses net
91K
-
731K
703.30%
326K
55.40%
-20K
106.13%
136K
780%
179K
31.62%
1.32M
639.66%
106K
91.99%
-112K
205.66%
-747K
566.96%
-95K
87.28%
income before tax
34.19M
-
31.69M
7.30%
29.67M
6.38%
27.12M
8.59%
40.33M
48.68%
70.55M
74.94%
92.36M
30.92%
134.26M
45.37%
216.13M
60.97%
184.06M
14.84%
128.80M
30.02%
income tax expense
10.22M
-
10.66M
4.36%
10.10M
5.25%
9.29M
8.09%
12.61M
35.73%
14.76M
17.09%
14.45M
2.11%
31.41M
117.39%
52.10M
65.89%
40.49M
22.28%
29.38M
27.44%
net income
23.97M
-
13.18M
45.01%
20.06M
52.17%
17.84M
11.08%
27.72M
55.43%
55.79M
101.25%
77.92M
39.66%
102.86M
32.01%
164.03M
59.47%
143.57M
12.48%
99.42M
30.75%
weighted average shs out
13.77M
-
12.67M
8.01%
11.96M
5.61%
11.84M
0.98%
11.92M
0.69%
11.95M
0.19%
11.77M
1.47%
11.77M
0%
11.71M
0.56%
11.20M
4.36%
10.88M
2.78%
weighted average shs out dil
13.82M
-
12.78M
7.52%
12.07M
5.54%
11.95M
1.03%
12.09M
1.18%
12.08M
0.07%
12.12M
0.31%
11.85M
2.20%
11.81M
0.31%
11.28M
4.55%
10.92M
3.15%
eps
1.74
-
1.04
40.23%
1.68
61.54%
1.51
10.12%
2.32
53.64%
4.67
101.29%
6.62
41.76%
8.74
32.02%
14.01
60.30%
12.82
8.49%
9.13
28.78%
epsdiluted
1.73
-
1.03
40.46%
1.66
61.17%
1.49
10.24%
2.29
53.69%
4.62
101.75%
6.43
39.18%
8.68
34.99%
13.89
60.02%
12.73
8.35%
9.10
28.52%

All numbers in USD (except ratios and percentages)